Sodium-glucose co-transporter 2 inhibition with empagliflozin improves cardiac function in non-diabetic rats with heart failure after myocardial infarction
Event: Heart Failure 2019
Topic: Pharmacotherapy
Session: Moderated Poster Session - Basic Science
